Chromatography in the Biotechnology Companies, Innovation and Supply Chain Analysis 2026

Top Companies in Chromatography in the Biotechnology Market & Their Offerings

All your Market data, trends, strategies, compititor insights and 30+ more features for you - in one place.
Click to access the dashboard

Supply Chain Analysis

R&D

• Research and development in chromatography for biotechnology is centered on improving separation efficiency, accuracy, and processing speed, especially for complex biologics such as monoclonal antibodies, mRNA-based products, and cell therapies. Continuous innovation aims to enhance productivity and scalability in bioprocessing.
• Key Players: Thermo Fisher Scientific, Cytiva, Agilent Technologies, and Merck KGaA.

Clinical Trials

• Chromatography plays a crucial role in biotechnology clinical trials by enabling the purification of biopharmaceuticals, studying drug behavior in the body (ADME), and assessing bioactivity in complex biological samples. It supports accurate analysis and reliable results throughout drug development.
• Key players: Waters Corporation, Shimadzu Corporation, PerkinElmer, and Bio-Rad Laboratories.

Regulatory Approvals

• Regulatory approval of chromatography in biotechnology focuses on maintaining product safety, purity, and effectiveness. Techniques like HPLC, UHPLC, and affinity chromatography must be properly validated to meet global regulatory and GMP requirements, ensuring consistent removal of impurities in biologics. Compliance with international guidelines is critical throughout development and manufacturing.
• Key players: Danaher Corporation, GE Healthcare, Sartorius AG, and Restek Corporation.

Market Forecast 2026-2035

The global chromatography in the biotechnology market size was estimated at USD 11.8 billion in 2025 and is predicted to increase from USD 12.85 billion in 2026 to approximately USD 27.68 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035.

Want to explore before committing? Our sample is personalized to your business needs.
Get it for free now

The Pharmaceutical Companies Segment held the Largest Market Share in 2025

Explanation

• Pharmaceutical Companies account for 42% of the market, leading due to their significant demand for research, development, and manufacturing of drugs and therapies.
• Biotechnology Companies represent 21% of the market, focusing on the development of biopharmaceuticals and genetic therapies, though they hold a smaller share compared to pharmaceutical companies.
• Academic & Research Institutions hold 16% of the market, playing a key role in scientific studies and innovations, but with a smaller share compared to industry-focused end-users.
• Hospitals & Diagnostic Labs account for 12% of the market, supporting clinical care and diagnostics, though they hold a smaller share in comparison to pharmaceutical and biotechnology companies.
• CROs make up 9% of the market, providing outsourced research and clinical trials services, but they represent the smallest share among the end-users.

Pharmaceutical companies held the largest market share in chromatography in the biotechnology market by 42% in 2025 due to their extensive use of chromatography in drug development, quality control, and regulatory compliance. High investment in research and development, increasing production of biologics and small-molecule drugs, and strict safety standards drive demand. Additionally, the need for precise separation and analysis of complex compounds makes chromatography essential, ensuring consistent product quality and supporting large-scale manufacturing operations.

The biotechnology companies segment is expected to grow at the fastest CAGR due to increasing focus on biologics, gene therapies, and personalized medicine. These companies rely heavily on chromatography for protein purification and biomolecule analysis. Rising investment, expanding research pipelines, and growing demand for innovative therapies drive adoption. Additionally, advancements in biotech processes and the need for high-precision separation technologies further accelerate chromatography usage in the rapidly evolving segment.

What are the Recent Developments in Chromatography in the Biotechnology Market?

• In June 2025, advanced LC-MS integrated chromatography platforms improved sensitivity for complex biomolecule detection.